GLP-1 medications are prescribed on a titration schedule because starting at the highest dose would make side effects much harder to tolerate. Ozempic starts at 0.25 mg and titrates to 0.5 mg, 1 mg, or 2 mg. Wegovy uses 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, and its June 2026 label adds an optional 7.2 mg dose for adults using it for weight reduction. Zepbound starts at 2.5 mg and can move up in 2.5 mg steps to 15 mg. Mounjaro also starts at 2.5 mg, but since August 2026 its label says to increase only if more blood sugar control is needed. The normal pattern is that nausea, fullness, constipation, diarrhea, reflux, or fatigue may flare again after each increase, then improve as the dose stays stable. [1] [2] [3] [4]
That is the practical reason titration matters. A lot of people feel okay at one level, then assume something is going wrong when the next increase hits harder. Often it is not a new problem. It is the same biologic adjustment pattern repeating at a stronger dose.
There is one important honesty note before the tables: the public evidence does not give a perfect symptom percentage for every single 4-week dose step. What we have instead is a mix of current FDA labels, pivotal trials, and pooled tolerability analyses. That is enough to build a useful guide, but not enough to pretend there is a precise nausea number for every week of every ladder. [5] [6] [7] [8]
If you want the broader class overview first, start with our complete guide to GLP-1 medications. For the symptom pattern over time, keep GLP-1 side effects by week, how to manage GLP-1 nausea, and best foods to eat on GLP-1 medications open too.
Why Are GLP-1 Doses Increased Slowly?
The labels are explicit about the logic: dose escalation is used to reduce gastrointestinal adverse reactions. [1] [2] [3] [4] That matches the pooled trial data. In the semaglutide obesity program, nausea affected 43.9% of participants, diarrhea 29.7%, vomiting 24.5%, and constipation 24.2%, and those events happened most often during or shortly after dose escalation. [7] Across SURMOUNT-1 to -4, tirzepatide GI events were also more common than placebo and occurred mainly during escalation. [8]
So titration is not busywork. It is the safety and tolerability strategy. It gives your stomach, appetite signaling, meal size, and hydration routine time to catch up before the next step.
What Are the Dose Schedules for Ozempic, Wegovy, Mounjaro, and Zepbound?
Semaglutide: Ozempic and Wegovy
| Weeks | Ozempic | Wegovy | What usually changes |
|---|---|---|---|
| 1-4 | 0.25 mg | 0.25 mg | Starter dose. Some people feel very little; others notice earlier fullness, smaller appetite, or mild nausea after meals. [1] [2] |
| 5-8 | 0.5 mg | 0.5 mg | First real escalation. This is a common point for nausea, reflux, constipation, or fatigue to return after a calmer week 4. [1] [2] [7] |
| 9-12 | 0.5 mg, or 1 mg if more blood sugar control is needed | 1 mg | Appetite suppression is often clearer. Meal size errors become more obvious, and “I was fine until I ate like before” becomes common. [1] [2] [9] |
| 13-16 | 1 mg, or 2 mg if more control is needed after at least 4 weeks on 1 mg | 1.7 mg | Wegovy’s jump to 1.7 mg is often the point where readers notice a stronger dose-increase dip if they were barely tolerating 1 mg. [2] [7] |
| 17+ | Maintenance of 0.5, 1, or 2 mg (2 mg is the maximum) | 2.4 mg maintenance (recommended), or 1.7 mg | Standard maintenance level. Symptoms should settle if the dose fits; if they do not, forcing the schedule is the wrong lesson. [1] [2] [5] [7] |
| 21+ (optional) | Not applicable | 7.2 mg for adults using Wegovy for weight reduction, after at least 4 weeks on 2.4 mg if more weight loss is clinically indicated | In the 7.2 mg trials, nausea (39% vs 35%), vomiting (22% vs 16%), and dysesthesia, a burning or tingling skin feeling (22% vs 6%), were more common than on 2.4 mg. [2] |
For adults with type 2 diabetes and chronic kidney disease, the Ozempic label sets the maintenance dose at 1 mg after at least 4 weeks on 0.5 mg. [1] Our Wegovy 7.2 mg guide covers the higher dose in more detail.
Tirzepatide: Mounjaro and Zepbound
Both tirzepatide brands use the same 2.5 mg steps, at least 4 weeks apart, up to 15 mg. The difference is when to move up. Zepbound’s label says to increase from 2.5 mg to 5 mg after 4 weeks, because 2.5 mg is for starting treatment and is not approved as a maintenance dose. Its maintenance doses are 5, 10, or 15 mg for weight, or 10 or 15 mg for sleep apnea. [4] Since August 2026, Mounjaro’s label says to increase in 2.5 mg steps only if more blood sugar control is needed, with a maximum of 15 mg for adults and 10 mg for children. [3] The earlier Mounjaro label had called 2.5 mg a starting dose only and required the step to 5 mg. [12] The weeks below show the fastest the labels allow. Prescribers can move more slowly or stop at a lower maintenance dose.
| Weeks | Mounjaro or Zepbound | What usually changes |
|---|---|---|
| 1-4 | 2.5 mg | Starting dose for both. For Zepbound it is initiation only and not approved as a maintenance dose. This is the “learn the medication” month. [3] [4] |
| 5-8 | 5 mg | First maintenance-level step for Zepbound. In the Zepbound label, nausea is 25%, vomiting 8%, constipation 17%, and dyspepsia 9% at this level. [4] |
| 9-12 | 7.5 mg | Transitional step. Not every patient needs to race through it; many people feel another short dip in appetite, nausea, or bowel habits here. [3] [4] [8] |
| 13-16 | 10 mg | GI symptoms may return after the increase. The current Zepbound table reports nausea 29%, vomiting 11%, constipation 14%, and dyspepsia 9% at 10 mg. [4] |
| 17-20 | 12.5 mg | Another optional escalation step. This is often where tolerability, not ambition, should decide whether moving on makes sense. [3] [4] |
| 21+ | 15 mg | Highest labeled tirzepatide dose. Zepbound reports nausea 28%, vomiting 13%, constipation 11%, and dyspepsia 10% at 15 mg, with most nausea, vomiting, and diarrhea events occurring during escalation and decreasing over time. [4] |
Pills: Wegovy Tablets, Ozempic Tablets, Rybelsus, and Foundayo
The daily GLP-1 pills also start low, but they step up every 30 days instead of every 4 weeks.
| Pill | Days 1-30 | Days 31-60 | Days 61-90 | After that |
|---|---|---|---|---|
| Wegovy tablets (weight, heart risk) | 1.5 mg | 4 mg | 9 mg | 25 mg maintenance from day 91 [2] |
| Ozempic tablets (type 2 diabetes) | 1.5 mg | 4 mg | 4 mg, or 9 mg if more blood sugar control is needed | 4 mg or 9 mg [10] |
| Rybelsus (type 2 diabetes) | 3 mg | 7 mg | 7 mg, or 14 mg if more blood sugar control is needed | 7 mg or 14 mg [10] |
| Foundayo (weight) | 0.8 mg | 2.5 mg | 5.5 mg | May step up to 9 mg, 14.5 mg, and 17.2 mg (the maximum), at least 30 days apart [11] |
Ozempic tablets and Rybelsus contain the same drug but are not interchangeable milligram for milligram. The semaglutide pills are taken on an empty stomach in the morning with up to 4 ounces of water, followed by at least a 30-minute wait before food, drinks, or other oral medicines. Foundayo can be taken with or without food. [2] [10] [11] For how the two weight-loss pills compare, see Foundayo vs the Wegovy pill.
What to Expect at Each Step
Starting dose: “I barely feel it” can be normal
At the lowest dose, the most common mistake is thinking the drug is not working because it does not feel dramatic. That is especially true with Ozempic 0.25 mg and tirzepatide 2.5 mg, because both are intentionally low starter doses. [1] [3]
What is normal here:
- Little or no obvious appetite change
- Mild early fullness
- Some nausea if you eat quickly or eat a heavy meal
- Mild constipation if intake drops faster than fluids do
What is not smart here is chasing proof by overeating. A starter dose is supposed to be tolerable enough to repeat next week.
First increase: the most common “dose increase dip”
The move from semaglutide 0.25 to 0.5 mg, or tirzepatide 2.5 to 5 mg, is where many people first say, “Now I really feel it.” That makes sense. It is the first step where the medication is doing more than orientation-level work.
This is often when people notice:
- Nausea returning after meals
- Much stronger fullness on smaller portions
- Fatigue because they are suddenly under-eating
- Reflux or burping after normal pre-GLP-1 dinner sizes
- Constipation because total food volume and fluid intake both fell
The pooled semaglutide and tirzepatide tolerability analyses both support that broad pattern: GI events cluster during escalation, are usually mild to moderate, and explain only a small share of total weight loss. [7] [8]
Mid-escalation: side effects often become more predictable, not more mysterious
At mid-level doses, the pattern is usually less “random” than it feels. Appetite suppression is stronger. High-fat foods are less appealing. The margin for overeating is smaller. [9] That means symptoms often track behavior plus timing:
- rougher right after the weekly shot
- rougher after restaurant meals
- rougher when dinner is too large or too late
- better when the dose stays stable for a few weeks
This is also the phase where readers often confuse efficacy with intolerance. Losing weight, thinking less about food, and feeling full much faster can all be signs the drug is working. The problem is when those same effects push you into persistent vomiting, inadequate hydration, or week-after-week inability to function.
Maintenance dose: the goal is stability, not winning a toughness contest
The right maintenance dose is the lowest one that gives enough benefit with acceptable side effects. That is a clinical decision, not a status symbol. Ozempic has multiple maintenance options. Zepbound explicitly tells prescribers to consider treatment response and tolerability when selecting the maintenance dose and to consider a lower maintenance dose if the current one is not tolerated. Wegovy’s label also says to consider treatment response and tolerability when choosing its maintenance dose. [1] [2] [4]
If you are miserable every week on a “higher” dose, that is not proof you are doing treatment correctly. It may just mean you were escalated past the dose your body handles well.
Why Do Side Effects Come Back After a Dose Increase?
The practical pattern is straightforward:
- You may feel worse in the days after the increase.
- Meals have to get smaller again.
- Your gut settles if the dose fits.
- The next increase may repeat the cycle.
That is why a bad week after a higher dose is not automatically a sign the medication is wrong for you. It may be the expected escalation dip. The question is whether you recover.
The labels and pooled analyses align on this. Wegovy and Zepbound both describe GI symptoms as common during escalation. The pooled semaglutide and tirzepatide analyses add that these symptoms are usually non-serious and transient. [2] [4] [7] [8]
How Can You Tell If a GLP-1 Dose Is Too High?
More consistent with normal adjustment
- Mild nausea that fades later in the week
- Smaller meals fixing the problem
- Temporary constipation after a recent increase
- Fatigue that improves when protein, fluids, and total calories improve
- Appetite suppression without repeated vomiting
More consistent with “this dose may be too much”
- You still cannot eat or drink normally by the time the next shot is due
- Vomiting repeats instead of staying occasional
- You are losing fluids faster than you can replace them
- Week after week gets worse instead of better
- The medication is clearly disrupting work, sleep, or basic function on a stable dose
Not a routine side effect problem
- severe persistent abdominal pain
- repeated vomiting with inability to keep fluids down
- jaundice or dark urine
- fainting or confusion
- vomiting blood or black stools
Those are the situations where you stop asking whether this is a “normal titration dip” and start asking for medical evaluation. [1] [2] [3] [4]
The Medication Guides name several of these directly: severe stomach pain that will not go away (possible pancreatitis), yellowing of the skin or eyes with upper stomach pain or fever (possible gallbladder problems), and nausea, vomiting, or diarrhea that does not go away, which can cause dehydration and kidney problems. All four labels also carry a warning that GI side effects can sometimes be severe. In the weight-loss trials, severe GI reactions were reported in 4.1% of people on Wegovy injections versus 0.9% on placebo, and in 1.7% to 3.1% of people on Zepbound versus 1% on placebo. The labels say these drugs are not recommended for people with severe gastroparesis, and they tell prescribers to monitor kidney function when side effects could cause dehydration, especially when starting or raising the dose. [1] [2] [3] [4]
What to Eat During Dose Increase Weeks
There is no trial called “best foods during the week you move from 0.5 mg to 1 mg.” The honest evidence is more indirect. Semaglutide lowers hunger, lowers energy intake, and reduces preference for high-fat foods. [9] The labels and GI tolerability studies show that nausea, reflux, vomiting, and constipation are more common during escalation. [2] [4] [7] [8]
That is why the practical food advice is simple:
- smaller meals beat “healthy but huge” meals
- lower-fat meals usually beat rich meals
- slower eating usually beats trying to finish your old portion
- cold or bland foods often go down easier than hot, greasy, or strongly scented meals
- protein still matters, but liquids or soft proteins may work better on rough days
Good escalation-week defaults:
- Greek yogurt, cottage cheese, or a protein shake
- eggs and toast
- soup with crackers
- rice, applesauce, bananas, potatoes, or oatmeal
- lean chicken or fish in smaller portions
If nausea is your main problem, see our GLP-1 nausea guide. If food choices are the bigger issue, go to best foods for GLP-1 medications.
How Prescribers Decide When to Stop Increasing
There is no universal rule that everyone must end up at the highest dose. The real decision usually comes down to three questions:
- Is the current dose giving enough benefit?
- Are the side effects settling between injections?
- Would the next increase likely help more than it hurts?
For Ozempic, maintenance can be 0.5 mg, 1 mg, or 2 mg depending on the treatment goal. [1] For tirzepatide, the weight-management label gives multiple maintenance options and explicitly frames the choice around response and tolerability. [4] For Mounjaro, the August 2026 label ties each increase to whether more blood sugar control is needed. [3] For Wegovy, 2.4 mg is the recommended maintenance dose, 1.7 mg is an alternative, and adults using it for weight reduction may go to 7.2 mg after at least 4 weeks on 2.4 mg if more weight loss is clinically indicated. [2]
The Wegovy label also says that if a dose is not tolerated during escalation, prescribers can consider delaying the next increase by 4 weeks. If 2 or more Wegovy injections in a row are missed, it says to restart escalation at a lower dose to reduce the risk of GI side effects. [2] Missed-dose windows differ by product: within 5 days for Ozempic and within 4 days for Mounjaro and Zepbound. [1] [3] [4]
That means “stopping the climb” at a lower dose is not automatically undertreatment. Sometimes it is the most rational balance between efficacy and tolerability.
Practical Dose-Day Checklist
Use this before every increase:
- Did the last week’s symptoms mostly settle before today?
- Can I eat and drink normally enough to stay hydrated?
- Am I reducing portion size, or am I still testing my old meal habits?
- Is constipation already becoming a pattern?
- If I feel rough, is it because of the medication alone, or because I am under-eating, under-drinking, or eating too heavily at once?
- If I am already struggling, have I asked whether I should stay here longer instead of escalating on autopilot?
That last question is the one people skip most often. The schedule matters, but so does tolerability.
Bottom Line
GLP-1 titration works best when you expect a repeating pattern instead of a perfectly smooth climb. Each increase can briefly bring back nausea, fullness, constipation, reflux, or fatigue. That is why the products are escalated in steps rather than started at the top.
The part that matters most is not whether you feel symptoms at all. It is whether the pattern still looks like routine adjustment. If you recover as the dose stabilizes, that is usually normal. If you keep sliding backward, cannot stay hydrated, or are still miserable by the next injection, that is when the dose itself may need to change.
If you want more practical GLP-1 guides like this, join the email list for dose-day checklists, symptom timelines, and evidence-based food guides.
